What is the Regional Demand Outlook for Respiratory Syncytial Virus Diagnostics

Fact.MR, a market research and competitive intelligence provider, projects the global respiratory syncytial virus (RSV) diagnostics market to progress positively, surging at a CAGR of above 9% across the 2021-2031 forecast period.

Growing demand for point of care testing of respiratory syncytial virus (RSV)-infected patients and developments in the field of specific markers such as proteomics and genomic are set to accelerate market growth over the coming years.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=6736

Increase in the number of patients suffering from RSV infections has raised the overall burden of the disease, and, as such, has fuelled demand for RSV diagnostics globally. Approval of respiratory syncytial virus diagnostic assays & kits is further opening up various opportunities for market players.

North America dominates the market for respiratory syncytial virus diagnostics due to advanced technologies and innovation across the region, while the market in Asia Pacific is expected to surge at a high growth rate over the forecast period due to increasing burden of RSV infections among the population.

Key Takeaways from Market Study

• Market for respiratory syncytial virus diagnostics to grow 2.3X in value by 2031, and reach a valuation of US$ 1.3 Bn by 2031.
• RSV diagnostic kits & assays account for more one-third of the global market share.
• Market for RSV diagnostics in China to top US$ 253 Mn by 2031.
• Demand for respiratory syncytial virus diagnostics in Canada to increase at CAGR of 7.4%.
• Market in Japan anticipated to expand at CAGR of 6% from 2021 to 2031.
• New technological advancements in the field of diagnostics to boost market growth over next 10 years.

For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=6736

Key Market Segments Covered in Respiratory Syncytial Virus Diagnostics Industry Research

By Technology

• RSV Molecular Diagnostics
• RSV Monoclonal Antibodies
• Immunoassays
• Differential Light Scattering
• Artificial Intelligence
• Liposomes

By End Users

• Respiratory Syncytial Virus Diagnostics at Hospitals
• Respiratory Syncytial Virus Diagnostics at Nursing Homes
• Respiratory Syncytial Virus Diagnostics at Commercial Laboratories
• Respiratory Syncytial Virus Diagnostics at Public Health Laboratories

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/6736

Winning Strategy of Key Market Players 

Various companies are focusing on organic growth strategies such as product launches, product approvals, and patents. Inorganic growth activities witnessed in the market are acquisitions and partnership & collaborations.

Most companies are focussed on developing new and easy-to-use RSV diagnostic kits. Approval of technologically advanced diagnostic methods is expected to boost market growth over the coming years.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/27/2007702/0/en/Tricuspid-Valve-Repair-Market-Poised-for-Astounding-Growth-Through-2029-Fact-MR-Projects-Annuloplasty-Rings-to-Remain-Top-Selling.html

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com